3/7
12:22 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
3/7
12:22 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
3/7
10:01 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $33.00 price target on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $33.00 price target on the stock.
3/7
10:01 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $33.00 price target on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $33.00 price target on the stock.
3/5
12:24 pm
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $35.00 price target on the stock, down previously from $38.00.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $35.00 price target on the stock, down previously from $38.00.
3/5
12:24 pm
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $35.00 price target on the stock, down previously from $38.00.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $35.00 price target on the stock, down previously from $38.00.
3/3
12:54 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
3/3
12:54 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
2/28
12:30 pm
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
2/28
12:30 pm
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
2/11
12:59 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
2/11
12:59 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
2/11
05:22 am
dnli
Denali Therapeutics initiated with a Buy at Deutsche Bank
Medium
Report
Denali Therapeutics initiated with a Buy at Deutsche Bank
2/11
05:22 am
dnli
Denali Therapeutics initiated with a Buy at Deutsche Bank
Medium
Report
Denali Therapeutics initiated with a Buy at Deutsche Bank
1/15
08:13 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
High
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
1/15
08:13 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
High
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at William Blair.
1/7
02:09 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
1/7
08:04 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $31.00 price target on the stock.
High
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $31.00 price target on the stock.
1/7
05:15 am
dnli
Rating for DNLI
High
Report
Rating for DNLI
1/7
05:15 am
dnli
Rating for DNLI
High
Report
Rating for DNLI
1/7
05:02 am
dnli
Denali Therapeutics initiated with an Outperform at Baird
High
Report
Denali Therapeutics initiated with an Outperform at Baird
1/7
05:02 am
dnli
Denali Therapeutics initiated with an Outperform at Baird
High
Report
Denali Therapeutics initiated with an Outperform at Baird
1/6
04:10 pm
dnli
Denali Therapeutics initiated with an Outperform at Baird
Medium
Report
Denali Therapeutics initiated with an Outperform at Baird
1/6
04:10 pm
dnli
Denali Therapeutics initiated with an Outperform at Baird
Medium
Report
Denali Therapeutics initiated with an Outperform at Baird
1/3
09:05 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI